Ctt Pharmaceutical Holdings annual free cash flow
2025
Ctt Pharmaceutical Holdings Free Cash Flow (FCF) History (CTTH)
Ctt Pharmaceutical Holdings reported −$79,780 in free cash flow for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$79,780 | — | — | — |
Ctt Pharmaceutical Holdings quarterly free cash flow
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$19,231 | — | — | — |
Ctt Pharmaceutical Holdings free cash flow growth trends
Ctt Pharmaceutical Holdings's latest reported quarter, Q4 2025, generated −$19,231 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Ctt Pharmaceutical Holdings source filings ↗